customer service software
0

Rosetta Genomics Ltd - Medical Equipment - Deals and Alliances Profile

  • Published Date: 14 Dec 2018
  • Number of Pages: 59
  • Category: Company Profile
  • Country: Israel
Summary

Rosetta Genomics Ltd (RGL) is a developer of next generation diagnostic tests for personalized medicine. The company provides testing services such as cancer origin, next-gen, thyroid, lung, prostate, bladder, breast, kidney and specialty tests. It also develops tests for thyroid neoplasia, oncology, kidney rejection, Alzheimers disease, therapeutics and CMV. The company offers RosettaGX platform on the cutting edge of molecular science and genomic testing technologies, with tests. It operates in Australia, New Zealand, Israel, Singapore, Canada, Greece, India, Saudi Arabia, Qatar, the UAE, Israel and Turkey. RGL is headquartered in Rehovot, Israel.

Rosetta Genomics Ltd - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData


List of Tables 5
List of Figures 5
Rosetta Genomics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Rosetta Genomics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Rosetta Genomics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Rosetta Genomics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 10
Rosetta Genomics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Rosetta Genomics Ltd, Medical Equipment, Deal Details 13
Partnerships 13
Rosetta Genomics To Enter Into Licensing Agreement For microRNA Intellectual Property And Technology 13
Rosetta Enters Into Licensing Agreement For Patents Related To Cancer Applications 14
Genoptix Enters into Distribution Agreement with Rosetta Genomics 15
Rosetta Genomics Enters into Distribution Agreement with Cytolog Labs 16
Rosetta Genomics Enters into Co-Promotion Agreement with Precipio Diagnostics 17
Rosetta Genomics Enters into Co-Marketing Agreement with Admera Health 18
Rosetta Genomics Enters into Co-Development Agreement with Institute of Molecular Translational Medicine 19
Rosetta Genomics Enters into Co-Development Agreement with Global Pharma Company 20
Rosetta Genomics Enters into Co-Development Agreement with Moffitt Cancer Center 21
Rosetta Genomics Enters Into Co-Development Agreement With Rabin Medical 22
Rosetta Genomics Expands Distribution Agreement With Genekor 23
Rosetta Genomics Enters Into Agreement With Ramot To Develop Nano-Carrier Delivery System To Treat Cancer 24
Equity Offering 25
Rosetta Genomics Plans to Raise Funds through Public Offering of Shares 25
Rosetta Genomics Raises USD2.7 Million in Public Offering of Units 26
Rosetta Genomics Raises USD0.6 Million in Private Placement of Shares6 28
Rosetta Genomics Raises USD8 Million in Private Placement of Units 29
Rosetta Genomics Raises USD5 Million in Second and Final Tranche of Private Placement of Shares 30
Rosetta Genomics Raises USD5 Million in First Tranche of Private Placement of Shares 31
Rosetta Genomics Files Shelf Registration Statement For Public Offering Of Securities For Up To US$75 Million 32
Rosetta Genomics Completes Underwriters Exercise Of Over-Allotment Option For US$4 Million 33
Rosetta Genomics Completes Private Placement Of Shares For US$6.6 Million 34
Rosetta Genomics Completes Private Placement Of Shares For US$2 Million 35
Rosetta Genomics Completes Private Placement Of Shares For US$1.4 Million 36
Debt Offering 37
Rosetta Genomics Raises USD2 Million in Private Placement of Debentures and Warrants 37
Rosetta Genomics Raises USD1.3 Million in Second Tranche of Private Placement of Debentures and Warrants 38
Rosetta Genomics Raises USD3.2 Million in First Tranche of Private Placement of Debentures 39
Rosetta Genomics Completes Private Placement Of Debentures Due 2013 For US$1.75 Million 40
Asset Transactions 41
Interpace Diagnostics Acquires Philadelphia Laboratory from Rosetta Genomics 41
Acquisition 42
Genoptix to Acquire Rosetta Genomics for USD9 Million 42
Pragmin Prognosis to Acquire Cynogen from Rosetta Genomics for USD3 Million 44
Rosetta Genomics Acquires CynoGen (PersonalizeDx) from Prelude 45
Rosetta Genomics Ltd - Key Competitors 46
Rosetta Genomics Ltd - Key Employees 47
Rosetta Genomics Ltd - Locations And Subsidiaries 48
Head Office 48
Other Locations & Subsidiaries 48
Recent Developments 49
Strategy And Business Planning 49
Jul 06, 2017: Rosetta Genomics Expands Patent Portfolio in Canada, United States, and China 49
Financial Announcements 50
Oct 10, 2017: Rosetta Genomics Reports 2017 Second Quarter and Six Months Financial Results 50
Mar 30, 2017: Rosetta Genomics Reports 2016 Fourth Quarter and Full Year Financial Results 53
Corporate Communications 55
Apr 10, 2018: Rosetta Announces Resignation of Kenneth Berlin as President and CEO 55
Legal and Regulatory 56
Jul 18, 2018: Delisting of Securities of Rosetta Genomics, ConvergeOne Holdings, (Warrant Only), FC Global Realty, Concordia International, and Argos Therapeutics from The Nasdaq Stock Market 56
Product News 57
May 01, 2017: Rosetta Genomics Expands Patent Portfolio in Europe and Japan 57
Other Significant Developments 58
Sep 05, 2017: Rosetta Genomics to Reduce Operating and Other Expenses 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59

List Of Tables


Rosetta Genomics Ltd, Medical Equipment, Key Facts, 2016 2
Rosetta Genomics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Rosetta Genomics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Rosetta Genomics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Rosetta Genomics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Rosetta Genomics Ltd, Deals By Market, 2012 to YTD 2018 10
Rosetta Genomics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Rosetta Genomics To Enter Into Licensing Agreement For microRNA Intellectual Property And Technology 13
Rosetta Enters Into Licensing Agreement For Patents Related To Cancer Applications 14
Genoptix Enters into Distribution Agreement with Rosetta Genomics 15
Rosetta Genomics Enters into Distribution Agreement with Cytolog Labs 16
Rosetta Genomics Enters into Co-Promotion Agreement with Precipio Diagnostics 17
Rosetta Genomics Enters into Co-Marketing Agreement with Admera Health 18
Rosetta Genomics Enters into Co-Development Agreement with Institute of Molecular Translational Medicine 19
Rosetta Genomics Enters into Co-Development Agreement with Global Pharma Company 20
Rosetta Genomics Enters into Co-Development Agreement with Moffitt Cancer Center 21
Rosetta Genomics Enters Into Co-Development Agreement With Rabin Medical 22
Rosetta Genomics Expands Distribution Agreement With Genekor 23
Rosetta Genomics Enters Into Agreement With Ramot To Develop Nano-Carrier Delivery System To Treat Cancer 24
Rosetta Genomics Plans to Raise Funds through Public Offering of Shares 25
Rosetta Genomics Raises USD2.7 Million in Public Offering of Units 26
Rosetta Genomics Raises USD0.6 Million in Private Placement of Shares6 28
Rosetta Genomics Raises USD8 Million in Private Placement of Units 29
Rosetta Genomics Raises USD5 Million in Second and Final Tranche of Private Placement of Shares 30
Rosetta Genomics Raises USD5 Million in First Tranche of Private Placement of Shares 31
Rosetta Genomics Files Shelf Registration Statement For Public Offering Of Securities For Up To US$75 Million 32
Rosetta Genomics Completes Underwriters Exercise Of Over-Allotment Option For US$4 Million 33
Rosetta Genomics Completes Private Placement Of Shares For US$6.6 Million 34
Rosetta Genomics Completes Private Placement Of Shares For US$2 Million 35
Rosetta Genomics Completes Private Placement Of Shares For US$1.4 Million 36
Rosetta Genomics Raises USD2 Million in Private Placement of Debentures and Warrants 37
Rosetta Genomics Raises USD1.3 Million in Second Tranche of Private Placement of Debentures and Warrants 38
Rosetta Genomics Raises USD3.2 Million in First Tranche of Private Placement of Debentures 39
Rosetta Genomics Completes Private Placement Of Debentures Due 2013 For US$1.75 Million 40
Interpace Diagnostics Acquires Philadelphia Laboratory from Rosetta Genomics 41
Genoptix to Acquire Rosetta Genomics for USD9 Million 42
Pragmin Prognosis to Acquire Cynogen from Rosetta Genomics for USD3 Million 44
Rosetta Genomics Acquires CynoGen (PersonalizeDx) from Prelude 45
Rosetta Genomics Ltd, Key Competitors 46
Rosetta Genomics Ltd, Key Employees 47
Rosetta Genomics Ltd, Other Locations 48
Rosetta Genomics Ltd, Subsidiaries 48

List Of Figures


Rosetta Genomics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Rosetta Genomics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Rosetta Genomics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Rosetta Genomics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Rosetta Genomics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Rosetta Genomics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 8
Rosetta Genomics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Rosetta Genomics Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 10

MGC Diagnostics Corp (MGC Diagnostics) is a medical device company that provides cardio respiratory health solutions. The company provides PFT, metabolic CPET and CPX and indirect calorimetry products. Its PFT

View Report

Spectranetics Corp (Spectranetics) is a medical device company that manufactures and distributes disposable medical devices. The company provides peripheral intervention, lead management and coronary intervention products. It offers peripheral and

View Report

Flagship Biosciences Inc (Flagship Biosciences) is a drug development company that provides proprietary tissue analysis technology. The company provides precision medicine by quantifying and simplifying complex pathology. It has quantitative

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit -

Cick Here